You’re offline. This is a read only version of the page.
Skip to main content
Toggle navigation
Home
Our data
Our data
Approved projects
Datasets and Linkage
Pricing and packages
Platform information
Request data access
News and Events
News and Events
Acknowledgements
About
About
Secure data environment
Public involvement
Our Impact
Data Access Committee
Barts Charity
Meet the team
Contact Us
Contact Us
FAQs
Search
Sign in
Contrast:
By clicking the "Accept Basic" button below, you agree to the minimum cookies needed to operate the website. By clicking the 'Accept All' button you agree to additional cookies needed for website analytics. More details are in our
Privacy Policy
.
Close Box
Accept Basic Cookies
Accept All Cookies
Project Summary
Project Title
*
General Project Information
Project Type
Research
Clinical Audit
Quality Improvement
Service Evaluation
Research - OMOP (CYBORG)
Clinical - OMOP (CYBORG)
Approval Type
Full
Provisional
Planned Project Start Date
*
Planned Project End Date
*
Overall Status
*
Project Summary
*
<div class="ck-content" data-wrapper="true" dir="ltr" style="--ck-image-style-spacing: 1.5em; --ck-inline-image-style-spacing: calc(var(--ck-image-style-spacing) / 2); font-family: 'Segoe UI','Helvetica Neue',sans-serif; font-size: 9pt;"><p class="xmsonormal" style="margin: 0cm;"><span style="font-family:Aptos, serif;font-size:12pt;">We have been undertaking work to improve the accuracy and speed of medication, to treat patients diagnosed with malaria, within our Trust. </span></p></div>
Detailed Project Description
*
<div class="ck-content" data-wrapper="true" dir="ltr" style="--ck-image-style-spacing: 1.5em; --ck-inline-image-style-spacing: calc(var(--ck-image-style-spacing) / 2); font-family: 'Segoe UI','Helvetica Neue',sans-serif; font-size: 9pt;"><div style="font-family:'Segoe UI','Helvetica Neue',sans-serif;font-size:9pt;">We have been undertaking a QI project to improve correct prescription and prompt administration of anti-malarial medication to patients with malaria across Barts trust. Anti-malarial medication should be administered as soon as possible, ideally within 1 hour, and according to the trust Malaria guidelines.</div><div style="font-family:'Segoe UI','Helvetica Neue',sans-serif;font-size:9pt;"> </div><div style="font-family:'Segoe UI','Helvetica Neue',sans-serif;font-size:9pt;">An audit of all cases of malaria for 5 years in our trust showed there were significant delays in administration of antimalarial medication and frequent examples of the wrong antimalarial medication being administered. We subsequently undertook QI work including education, awareness raising, updated guidelines on EOLAS, and a new EPMA bundle for malaria. We would like to re-audit the last 4 months of care following the EPMA bundle going live earlier this year.</div><div style="font-family:'Segoe UI','Helvetica Neue',sans-serif;font-size:9pt;"> </div><p style="margin: 0;">Aim: A project to improve the speed and accuracy of administration of anti-malarial medications to patients with<br>malaria in Barts Health NHS Trust.</p></div>
Requested Data Summary
*
<div data-wrapper="true" style="font-family:'Segoe UI','Helvetica Neue',sans-serif; font-size:9pt"><div>Hospital numbers and malarial species for all cases of malaria (Falciparum, Vivax, Ovale, Malariae, mixed) from 1st February 2025 to 16th June 2025 </div></div>
Technical Description
*
<div data-wrapper="true" style="font-family:'Segoe UI','Helvetica Neue',sans-serif; font-size:9pt"><div>We use an Microsoft Excel spreadsheet on the NHS sharepoint secure server to record and analyse data.</div></div>
Public and Patient Involvement and Engagement Summary
*
<div data-wrapper="true" style="font-family:'Segoe UI','Helvetica Neue',sans-serif; font-size:9pt"><div>Not applicable to this technically-focussed project.</div></div>
Reporting
*
<div data-wrapper="true" style="font-family:'Segoe UI','Helvetica Neue',sans-serif; font-size:9pt"><div>We have already presented the work at Federation of Infection Sciences conference December 2024 and plan to write up the project as a journal article after this re-audit cycle.</div></div>
Contact Points
Project Lead Name
*
Project Lead Position
*
Project Lead Email
*
Lead Organisation Name
*
Lead Organisation Address
*
Secure Data Environment (SDE)
Will you be using the BH SDE
Will you be using the BH SDE
No
Will you be using the BH SDE
Yes
Details of the location and IT system (the SDE) where the data extract will be kept and processed.
*